Advertisement
Journal Home
Search for

Volume 5, Issue 5, Pages 375-379 (September 2009)


View previous. 6 of 85 View next.

Severe Impairment Battery Language scale: A language-assessment tool for Alzheimer's disease patients

Steven FerrisaCorresponding Author Informationemail address, Ralf Ihlb, Philippe Robertc, Bengt Winbladd, Gudrun Gatze, Frank Tennigkeite, Serge Gauthierf

Abstract 

Background

Communication problems are common in Alzheimer's disease (AD) patients, but instruments to assess these symptoms are limited. Our objective was to create a new scale, based on the language subscale of the Severe Impairment Battery (SIB), as a sensitive and reliable measurement of treatment effects on language performance.

Methods

All 24 items of the SIB language subscale were chosen for analysis. Baseline scores of 1320 moderate-to-severe patients (Mini-Mental State Examination [MMSE] score, <15), from a combined AD database of four Memantine clinical trials (Study Codes: IE-2101, MEM-MD-01, MEM-MD-02, and MRZ-9605), were used for item reduction according to a standard principal components factor analysis. All items with loadings >0.5 on the identified factors were selected for inclusion in the new language scale. Correlations with existing AD scales were examined.

Results

The analysis indicated six factors, with 21 of 24 items showing loadings >0.5. The resulting 21-item SIB Language (SIB-L) scale exhibited high internal consistency (Cronbach's α = 0.809). The maximal SIB-L score was 41 points, with a measurement error of 3.7 points. The stratification of baseline SIB-L scores (mean, 31.7; SD, 8.4) by MMSE scores (mean, 9.7; SD, 3.3) showed a high variance in SIB-L scores. This confirms that patients with a low MMSE score can possess preserved language abilities. The SIB-L scale did not exhibit substantial floor-and-ceiling effects.

Conclusions

The new SIB-L is a fast (<15 minutes) and easily administered scale with favorable psychometric characteristics for assessing language impairment and treatment effects on the language performance of patients with moderate to severe AD.

a Alzheimer's Disease Center, New York University School of Medicine, New York, NY, and Nathan Kline Institute, Orangeburg, NY, USA

b Department of Psychiatry, University of Düsseldorf and Department of Geriatric Psychiatry, Alexian Hospital, Krefeld, Germany

c Memory Center, CHU - University of Nice Sophia Antipolis, Nice, France

d Alzheimer Center, Karolinska Institutet, Stockholm, Sweden

e Merz Pharmaceuticals, Frankfurt am Main, Germany

f McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada

Corresponding Author InformationCorresponding author. Tel.: 212-263-5703; Fax: 212-263-6991.

PII: S1552-5260(09)01350-8

doi:10.1016/j.jalz.2009.04.1236


View previous. 6 of 85 View next.